Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy

被引：0

作者：

Bergman, Martin

Buch, Maya ^{[1
]}

Tanaka, Yoshiya ^{[2
]}

Citera, Gustavo ^{[3
]}

Bahlas, Sami ^{[4
]}

Wong, Ernest ^{[5
]}

Song, Yanna ^{[6
]}

Tundia, Namita ^{[6
]}

Suboticki, Jessica ^{[6
]}

Strand, Vibeke ^{[7
]}

机构：

[1] Univ Leeds, Leeds, W Yorkshire, England

[2] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan

[3] Inst Rehabil Psicofis, Buenos Aires, DF, Argentina

[4] King Abdulaziz Univ, Med, Jeddah, Saudi Arabia

[5] Queen Alexandra Hosp, Rheumatol, Portsmouth, Hants, England

[6] AbbVie Inc, N Chicago, IL USA

[7] Stanford Univ, Sch Med, Portola Valley, CA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1234

引用

页码：2547 / 2549

页数：3

共 50 条

[21] Adalimumab clinical trial results in patients with rheumatoid arthritis (RA) provide proposed improvement categories for a routine assessment of patient index data (RAPID3)
Pincus, T.
Amara, I.
Koch, G.
Segurado, O.
ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S536 - S537
[22] RAPID3 (Routine Assessment of Patient Index Data 3) at Week 12 Predicts Progression of Joint Damage at Year 1 in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol Plus Methotrexate
Keystone, Edward
Davies, Owen
Luijtens, Kristel
Syrotuik, Jerry
JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1715 - 1715
[23] Routine Assessment of Patient Index Data-3 (RAPID3), a Patient-Reported Index to Guide a Treat-to-Target Strategy for Rheumatoid Arthritis in Usual Care
Bergman, Martin J.
Pincus, Theodore
Castrejon, Isabel
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S124 - S124
[24] CORRELATION BETWEEN ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3 (RAPID3) AND WOMAC IN ROUTINE CARE IN PATIENTS WITH KNEE OSTEOARTHRITIS
Lurati, A.
Bompane, D.
Re, K.
Marrazza, M.
Scarpellini, M.
OSTEOARTHRITIS AND CARTILAGE, 2014, 22 : S191 - S191
[25] Patient Reported Disease Activity including Joint Assessment: A Comparison of RADAI (Rheumatoid Arthritis Disease Activity Index) and RAPID3 (Routine Assessment of Patient Index Data 3) in Patients Treated with Certolizumab Pegol Over 12 Weeks
Weinblatt, Michael
Pope, Janet
Fleischmann, Roy
Bingham, Clifton
Coteur, Geoffroy
Dougados, Maxime
JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1707 - 1708
[26] Proposal to Re-Evaluate the Definition of Low Disease Activity in Routine Assesment of Patient Index Data 3 (RAPID3) in Rheumatoid Arthritis Patients
Tiwari, Vivekanand
Maheshwari, Ana
Dheer, Surjeet
Bergman, Martin J.
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[27] Correlation between the Routine Assessment of Patient Index Data (RAPID3) and Inflammatory Markers in Patients with PMR
Kolniak, Tiffany
Baker, Joshua
Danve, Abhijeet
Sehra, Shiv Tej
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[28] Patient-Reported Disease Activity Including Joint Assessment: A Comparison of RADAI (Rheumatoid Arthritis Disease Activity Index) and RAPID3 (Routine Assessment of Patient Index Data 3) in Patients Treated with Certolizumab Pegol Over 12 Weeks
Weinblatt, Michael E.
Pope, Janet E.
Fleischmann, Roy M.
Bingham, Clifton O.
Coteur, Geoffroy
Dougados, Maxime
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S480 - S481
[29] ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3 (RAPID3)-DEFINED REMISSION IS AS STRINGENT AS ACR/EULAR BOOLEAN-DEFINED REMISSION IN A CLINICAL TRIAL OF PATIENTS WITH EARLY RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT
Yazici, Y.
Gandhi, K. K.
Alemao, E.
Furst, D. E.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 440 - 441
[30] RAPID3 (Routine Assessment of Patient Index Data 3) At Week 12 Predicts Progression of Joint Damage At Year 1 in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol Plus Methotrexate.
Keystone, Edward
Davies, Owen
Luijtens, Kristel
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S170 - S170

← 1 2 3 4 5 →